Journal Information
Vol. 33. Issue 3.
Pages 148-150 (March 1997)
Share
Share
Download PDF
More article options
Vol. 33. Issue 3.
Pages 148-150 (March 1997)
Full text access
Hipertensión pulmonar primaria: tratamiento con prostaciclina como puente al trasplante pulmonar
Primary pulmonary hipertensión: transitional treatment with prostacyclin before lung transplantation
Visits
3678
P. Morales1, P.J. Cordero
Servicios de Neumología, Hospital Universitario La Fe. Valencia
L. Almenar*, R. Vicente**, F. Ramos**, J.M. Borro***
* Servicios de Cardiología, Hospital Universitario La Fe. Valencia
** Servicios de Anestesia y Reanimación, Hospital Universitario La Fe. Valencia
*** Servicios de Cirugía Torácica. Hospital Universitario La Fe. Valencia
This item has received
Article information

Presentamos la experiencia obtenida en 2 pacientes diagnosticados de hipertensión pulmonar primaria y posteriormente trasplantados que recibieron tratamiento con vasodilatadores pulmonares de acción corta (epoprostenol) como puente al trasplante pulmonar. En un primer paciente, varón de 19 años, se mantuvo el tratamiento en perfusión intravenosa continua, a dosis de 6ng/kg/min durante 26 días y en una segunda paciente, mujer de 49 años, a dosis inicial de 4ng/kg/min y posteriormente de 6ng/kg/min durante 6 meses. En ambos casos se redujo drásticamente la semiología previa, mejorando significativamente su calidad de vida.

Palabras clave:
Hipertensión pulmonar
Prostaciclina
Trasplante pulmonar

We report our experience with two patients diagnosed of primary pulmonary hypertension who later received lung transplants, with treatment with short-acting pulmonary vasodilators (epoprostenol) provided as a bridge to transplantation. Continuous intravenous perfusion at a dose of 6ng/kg/min was provided to the first patient, a 19-year-old man, for 26 days. An initial dose of 4ng/kg/min followed by 6ng/kg/min was given to the second patient, a 49-year-old woman, for 6 months. Symptoms were drastically reduced in both patients, significantly improving their quality of life.

Key words:
Pulmonary hypertension
Prostacyclin
Lung transplantation
Full text is only aviable in PDF
Bibliografía
[1.]
V. Fuster, P.M. Steele, W.D. Edwards, B.J. Gersh, M.D. McGoon, R.L. Frye.
Primary pulmonary hypertension: natural history and the importance of thrombosis.
Circulation, 70 (1984), pp. 580-587
[2.]
S. Rich, E. Kaufmann, P.S. Levy.
The effect of high doses of calciumchannel blockers on survival in primary pulmonary hypertension.
N Engl J Med, 327 (1992), pp. 76-81
[3.]
L.J. Rubin.
Primary pulmonary hypertension.
ACCP consensus statement. Chest, 104 (1993), pp. 236-250
[4.]
K. Bando, J.M. Armitage, I.L. Paradis, R.J. Keenan, R.L. Hardesty, H. Konishi, et al.
Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension.
J Thorac Cardiovasc Surg, 108 (1994), pp. 1.056-1.065
[5.]
L.J. Rubin, J. Mendoza, M. Hood, M. McGoon, R.J. Barst, W.B. Williams, et al.
Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial.
Ann Intern Med, 112 (1990), pp. 485-491
[6.]
D.K. Jones, T.W. Higenbottam, J. Wallwork.
Treatment of primary pulmonary hypertension with intravenous epoprostenol (prostacyclin).
Br Heart J, 57 (1987), pp. 270-278
[7.]
R.J. Barst, L.J. Rubin, W.A. Long, M.D. McGoon, S. Rich, D.B. Badesch, et al.
Primary pulmonary hypertension (prostacyclin) with conventional terapy for primary pulmonary hypertension.
N Engl J Med, 334 (1996), pp. 296-301
Copyright © 1997. Sociedad Española de Neumología y Cirugía Torácica
Archivos de Bronconeumología
Article options
Tools

Are you a health professional able to prescribe or dispense drugs?